Renowned cardiologists feel that children fixed with epicardial pacemakers may incur coronary artery compression a little more frequently than earlier thought. A review of patient records at Boston Children's Hospital led to the suggestion of stringent scrutinizing to diagnose children in danger of developing complications.
GE Healthcare has launched a second phase III (AURORA) clinical trial for using Flurpiridaz 18F Injection in positron-emission tomography (PET) myocardial perfusion imaging (MPI), in order to detect coronary artery disease (CAD).
Kibbutz Shefayim from an Israel-based startup company named Zebra Medical Vision announced that it has successfully received FDA clearance for an algorithm, which could aid physicians to quantify a patient’s coronary artery calcification.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.